John Salmeron from Durham, NC

Name / Title

Company / Classification

Phones & Addresses

John Salmeron
Principal

Salmeron Properties LLC
Nonresidential Building Operator

1308 Blackberry Ln, Hillsborough, NC 27278

Medicine Doctors

John Manuel Salmeron

view source

Specialties:

Anesthesiology

Education:

Universidad De Granada (1954)

Resumes

Chief Technology Officer

view source

Location:

Raleigh, NC

Industry:

Biotechnology

Work:

Global Agricultural Development Corporation
Board of Advisors Member
Ingateygen
Chief Technology Officer
Research Partners Ltd
Managing Director - S Research Partners, Llc - Translational Agriculture Strategy and Consulting
Precision Biosciences, Inc. Aug 2015 - May 2018
Director, Plantsciences Alliance Management
North Carolina State University Aug 2015 - May 2018
Adjunct Professor, Department of Plant and Microbial Biology

Education:

Washington University In St. Louis
Bachelors, Bachelor of Arts, Biology Duke University
Doctorates, Doctor of Philosophy, Genetics, Botany

Skills:

Biotechnology
Genomics
Molecular Biology
Life Sciences
Research
R&D
Genetics
Leadership
Technology Transfer
Lifesciences
Biochemistry
Agriculture
Science
Project Management
Strategy
Pharmaceutical Industry
Business Development
Protein Chemistry
Strategic Planning
Pcr
Portfolio Management
Assay Development
Bioinformatics
Business Strategy
Drug Discovery
Cross Functional Team Leadership
Change Management
Microbiology
Immunology
Biopharmaceuticals
Drug Development
Protein Purification
Project Planning

Interests:

Science and Technology
Education

Languages:

English
Spanish

Certifications:

Project Management Professional
Project Management Institute

John Salmeron

view source

John Salmeron

view source

Us Patents

Trichothecne-Resistant Transgenic Plants
view source
US Patent:

6346655, Feb 12, 2002
Filed:

Mar 29, 2000
Appl. No.:

09/538414
Inventors:

Thomas M. Hohn - Chapel Hill NC
Cheryl Peters - Raleigh NC
John Salmeron - Hillsborough NC
Assignee:

Syngenta Participations AG - Basel
International Classification:

C12N 1509
US Classification:

800279, 800278, 800288, 800298, 800295, 8003201, 8003203, 536 231, 536 232, 536 237, 435 691, 435419, 435468, 435430, 435177
Abstract:

The present invention discloses trichothecene-resistant transgenic plants, plant tissues, plant seeds, and plant cells comprising a heterologous polynucleotide encoding a gene product having tricothecene resistance activity that thereby confers trichothecene resistance to the transgenic plants, plant tissues, plant seeds, and plant cells. Trichothecene resistance activity, as used herein, refers to an activity that reduces or inhibits the phytotoxicity of a trichothecene, particularly to a fungus and/or plant. In a particular embodiment, trichothecene resistance activity refers to an activity that transfers an acetate to the C-3 position of a trichothecene such as T-2 toxin, HT-2 toxin, isotrichodermol, diacetoxyscirpenol (âDASâ), 3-deacetylcalonectrin, 3,15-dideacetylcalonectrin, scirpentriol, neosolaniol; 15-acetyldeoxynivalenol, nivalenol, 4-acetylnivalenol (fusarenone-X), 4,15-diacetylnivalenol, 4,7,15-acetylnivalenol, and deoxynivalenol (âDONâ) and their various acetylated derivatives. In another particular embodiment, the gene product having trichthecene resistance activity is a 3-O-acetyltransferase from a trichothecene-producing species of Fusarium, such as or.

Plant Genes And Uses Thereof
view source
US Patent:

6528702, Mar 4, 2003
Filed:

Mar 6, 2000
Appl. No.:

09/519232
Inventors:

John Manuel Salmeron - Hillsborough NC
Laura Jean Weislo - Raleigh NC
Michael G. Willits - Apex NC
Assignee:

Syngenta Participations AG - Basel
International Classification:

A01H 100
US Classification:

800278, 536 231, 536 236, 536 243, 435 701, 4353201, 435410, 435419, 435468, 800295
Abstract:

Homologues of the Arabidopsis NIM1 gene, which is involved in the signal transduction cascade leading to systemic acquired resistance (SAR), are isolated from (tobacco), (tomato), (oilseed rape), (sugarbeet), (sunflower), and (potato). The invention further concerns transformation vectors and processes for expressing the NIM1 homologues in transgenic plants to increase SAR gene expression and enhance broad spectrum disease resistance.

Trichothecene-Resistant Transgenic Plants
view source
US Patent:

6646184, Nov 11, 2003
Filed:

Feb 12, 2002
Appl. No.:

10/074279
Inventors:

Thomas M. Hohn - Chapel Hill NC
Cheryl Peters - Raleigh NC
John Salmeron - Hillsborough NC
Assignee:

Syngenta Participations AG - Basel
International Classification:

C12N 1509
US Classification:

800279, 800278, 800298, 800295, 8003201, 8003203, 800288, 536 237, 536 232
Abstract:

The present invention discloses trichothecene-resistant transgenic plants, plant tissues, plant seeds, and plant cells comprising a heterologous polynucleotide encoding a gene product having tricothecene resistance activity that thereby confers trichothecene resistance to the transgenic plants, plant tissues, plant seeds, and plant cells. Trichothecene resistance activity, as used herein, refers to an activity that reduces or inhibits the phytotoxicity of a trichothecene, particularly to a fungus and/or plant. In a particular embodiment, trichothecene resistance activity refers to an activity that transfers an acetate to the C-3 position of a trichothecene such as T-2 toxin, HT-2 toxin, isotrichodermol, diacetoxyscirpenol (âDASâ), 3-deacetylcalonectrin, 3,15-dideacetylcalonectrin, scirpentriol, neosolaniol; 15-acetyldeoxynivalenol, nivalenol, 4-acetylnivalenol (fusarenone-X), 4,15-diacetylnivalenol, 4,7,15-acetylnivalenol, and deoxynivalenol (âDONâ) and their various acetylated derivatives. In another particular embodiment, the gene product having trichthecene resistance activity is a 3-O-acetyltransferase from a trichothecene-producing species of Fusarium, such as or.

Nucleic Acid Molecules From Rice Encoding Rar1 Disease Resistance Proteins And Uses Thereof
view source
US Patent:

6956115, Oct 18, 2005
Filed:

Nov 27, 2002
Appl. No.:

10/305770
Inventors:

Manuel B. Sainz - Durham NC, US
John Salmeron - Hillsborough NC, US
Assignee:

Syngenta Participations AG - Basel
International Classification:

C12N015/29
C12N015/09
A01H005/00
US Classification:

536 236, 4353201, 435 691, 536 231
Abstract:

The present invention pertains to isolated nucleic acid molecules comprising nucleotide sequences isolated from that encode RARI proteins involved in disease resistance, and recombinant vectors comprising said nucleotide sequences.

Trichothecene-Resistant Transgenic Plants
view source
US Patent:

7049421, May 23, 2006
Filed:

Jul 7, 2003
Appl. No.:

10/614954
Inventors:

Thomas M. Hohn - Chapel Hill NC, US
Cheryl Peters - Raleigh NC, US
John Salmeron - Hillsborough NC, US
Assignee:

Syngenta Participations AG - Schwarzwaldallee
International Classification:

C12N 15/09
C12N 15/31
A01H 5/00
US Classification:

536 232, 536 237, 4353201
Abstract:

The present invention discloses isolated polynucleotides encoding polypeptides having trichothecene 3-O-acetyltransferase activity, recombinant vectors and host cell comprising said polynucleotides.

Transgenic Plants Compromising Nucleic Acid Molecules Encoding Rar1 Disease Resistance Proteins And Uses Thereof
view source
US Patent:

7098378, Aug 29, 2006
Filed:

Dec 14, 2004
Appl. No.:

11/011906
Inventors:

Manuel B. Sainz - Durham NC, US
John Salmeron - Hillsborough NC, US
Assignee:

Syngenta Participations AG - Basel
International Classification:

C12N 15/09
C12N 15/29
C12N 15/82
A01H 5/00
A01H 5/10
US Classification:

800279, 800278, 800298, 800295, 800317, 8003201, 435 691, 435468
Abstract:

The present invention pertains to transgenic plants comprising nucleic acid molecules comprising nucleotide sequences that encode RAR1 proteins involved in disease resistance, and the RAR1 polypeptides. The invention particularly relates to methods of altering the expressing nucleic acid molecules encoding RAR1 proteins in transgenic plants to alter the level disease resistance, and to transgenic plants, progeny and seed therefrom, having altered enhanced disease resistance. The invention further relates to methods of enhancing expression of R resistance genes, disease resistance signal transduction genes, genes involved in mediating disease resistance or involved in the synthesis of molecules mediating disease resistance. The invention also relates to methods of regulating the expression of other coding sequences of interest by increasing the expression of the nucleic acid molecules of the invention.

Isolated Bos1 Gene Promoters From And Uses Thereof
view source
US Patent:

7230159, Jun 12, 2007
Filed:

Mar 5, 2003
Appl. No.:

10/505744
Inventors:

Tesfaye Mengiste - West Lafayette IN, US
Xi Chen - Research Triangle Park NC, US
John Salmeron - Research Triangle Park NC, US
Robert Dietrich - Research Triangle Park NC, US
Assignee:

Syngenta Participations AG - Basel
International Classification:

C12N 15/82
C12N 15/09
A01H 5/00
US Classification:

800279, 800278, 800298, 536 241, 4353201, 435468
Abstract:

The present invention pertains to an isolated promoter sequence from BOSI gene encoding a protein for biotic and abiotic stress tolerance. Also, the invention relates to recombinant vectors, expression cassettes, host cells, plants or progeny thereof comprising nucleic acid molecules operably linked to said promoter.

Novel Plant Genes And Uses Thereof
view source
US Patent:

20030159171, Aug 21, 2003
Filed:

Dec 23, 2002
Appl. No.:

10/328675
Inventors:

John Salmeron - Hillsborough NC, US
Laura Weislo - Raleigh NC, US
Michael Willits - Apex NC, US
Assignee:

Syngenta Participations AG - Basel
International Classification:

A01H001/00
C12N015/82
C12Q001/68
C07H021/04
C07K014/415
C12N005/04
US Classification:

800/279000, 536/023600, 435/006000, 435/320100, 435/419000, 530/370000
Abstract:

Homologues of the Arabidopsis NIM1 gene, which is involved in the signal transduction cascade leading to systemic acquired resistance (SAR), are isolated from (tobacco), (tomato), (oilseed rape), (sugarbeet), (sunflower), and (potato). The invention further concerns transformation vectors and processes for expressing the NIM1 homologues in transgenic plants to increase SAR gene expression and enhance broad spectrum disease resistance.